Surface Mucin-1 does not play a role in dendritic cell migration.

[1]  Zhenglong Yuan,et al.  Down-regulation of MUC1 in cancer cells inhibits cell migration by promoting E-cadherin/catenin complex formation. , 2007, Biochemical and biophysical research communications.

[2]  A. Barakat,et al.  MUC1 is involved in trophoblast transendothelial migration. , 2007, Biochimica et biophysica acta.

[3]  J. Gratama,et al.  Cancer specific Mucin‐1 glycoforms are expressed on multiple myeloma , 2006, British journal of haematology.

[4]  P. Singh,et al.  RNA Interference Suppression of MUC1 Reduces the Growth Rate and Metastatic Phenotype of Human Pancreatic Cancer Cells , 2006, Clinical Cancer Research.

[5]  H. Shimizu,et al.  Presence of Circulating CCR10+ T cells and Elevated Serum CTACK/CCL27 in the Early Stage of Mycosis Fungoides , 2006, Clinical Cancer Research.

[6]  P. Krause,et al.  Prostaglandin E2 Is Generally Required for Human Dendritic Cell Migration and Exerts Its Effect via EP2 and EP4 Receptors1 , 2006, The Journal of Immunology.

[7]  Shinichi Watanabe,et al.  IL-17 suppresses TNF-alpha-induced CCL27 production through induction of COX-2 in human keratinocytes. , 2005, The Journal of allergy and clinical immunology.

[8]  B. Homey,et al.  Chemokine networks in atopic dermatitis: traffic signals of disease , 2005, Current allergy and asthma reports.

[9]  P. Delvenne,et al.  E‐cadherin‐dependent adhesion of dendritic and Langerhans cells to keratinocytes is defective in cervical human papillomavirus‐associated (pre)neoplastic lesions , 2005, The Journal of pathology.

[10]  P. Krause,et al.  Prostaglandin E 2 Is Generally Required for Human Dendritic Cell Migration and Exerts Its Effect via EP 2 and EP 4 Receptors 1 , 2005 .

[11]  J. Chow,et al.  MUC1 Mediates Transendothelial Migration in vitro by Ligating Endothelial Cell ICAM-1 , 2005, Clinical & Experimental Metastasis.

[12]  W. Germeraad,et al.  Mucin-1 is expressed on dendritic cells, both in vitro and in vivo. , 2004, International immunology.

[13]  Michael A. Hollingsworth,et al.  Mucins in cancer: protection and control of the cell surface , 2004, Nature Reviews Cancer.

[14]  Antonio Lanzavecchia,et al.  Regulation of Dendritic Cell Migration to the Draining Lymph Node , 2003, The Journal of experimental medicine.

[15]  J. Meza,et al.  Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line. , 2003, Cancer research.

[16]  J. Taylor‐Papadimitriou,et al.  Form and pattern of MUC1 expression on T cells activated in vivo or in vitro suggests a function in T‐cell migration , 2003, Immunology.

[17]  J. Meza,et al.  Contribution of the MUC 1 Tandem Repeat and Cytoplasmic Tail to Invasive and Metastatic Properties of a Pancreatic Cancer Cell Line 1 , 2003 .

[18]  J. Chung,et al.  Fructose‐1,6‐diphosphate attenuates prostaglandin E2 production and cyclo‐oxygenase‐2 expression in UVB‐irradiated HaCaT keratinocytes , 2002, British journal of pharmacology.

[19]  M. McGuckin,et al.  MUC1 epithelial mucin (CD227) is expressed by activated dendritic cells , 2002, Journal of leukocyte biology.

[20]  R. Förster,et al.  Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. , 2002, Blood.

[21]  R. Förster,et al.  Prostaglandin E 2 is a key factor for CCR 7 surface expression and migration of monocyte-derived dendritic cells , 2002 .

[22]  T. Brümmendorf,et al.  Expression of MUC-1 epitopes on normal bone marrow: implications for the detection of micrometastatic tumor cells. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  P. Delvenne,et al.  Colonization of in vitro-formed cervical human papillomavirus- associated (pre)neoplastic lesions with dendritic cells: role of granulocyte/macrophage colony-stimulating factor. , 1999, The American journal of pathology.

[24]  J. Hugh,et al.  MUC1 synthetic peptide inhibition of intercellular adhesion molecule-1 and MUC1 binding requires six tandem repeats. , 1998, Cancer research.

[25]  B. Longenecker,et al.  Expression of MUC1 mucin on activated human T cells: implications for a role of MUC1 in normal immune regulation. , 1998, Cancer research.

[26]  Y. Yamaguchi,et al.  EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. , 1998, Journal of immunology.

[27]  L. Pilarski,et al.  The breast mucin MUCI as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer. , 1996, Cancer research.

[28]  J. Dekker,et al.  Mucin gene structure and expression: protection vs. adhesion. , 1995, The American journal of physiology.

[29]  R. Dahiya,et al.  Heterogeneity of mucin gene expression in normal and neoplastic tissues. , 1993, Cancer research.